CompletedNot Applicable

Assessment of Oxidative Stress Contents in Jordanian Pregnant Women With Preeclampsia

Jordan90 participantsStarted 2022-11-01

Plain-language summary

Preeclampsia, a widespread complication affecting pregnant women globally, necessitates a thorough investigation into the role of oxidative stress in its manifestation. This study aimed to assess the oxidative stress markers-malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), and thioredoxin (Trx) in preeclamptic compared to healthy pregnant women

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Inclusion criteria specified pregnant women aged 20 to 40, diagnosed with preeclampsia based on blood pressure and proteinuria Exclusion Criteria: * applied to those with diabetes, liver or kidney diseases, cardiovascular diseases, or using specific supplements like vitamins A, C, and E.

What they're measuring

Oxadative stress parameters

Timeframe: 7 months

Thioredoxin and 4-Hydroxynonenal quantification, while malondialdehyde

Timeframe: 7 months

Trial details

NCT IDNCT07119034

SponsorFuture University in Egypt

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-11-10

View on ClinicalTrials.gov More Preeclampsia (PE) trials